A new study from the University of Texas, El Paso shows that stimulating the nerves in the ear can relieve people with pain in the knee osteoarthritis.
The study, conducted in collaboration with Harvard Medical School and Boston University, tested a non-invasive treatment that targets the vagus nerve through ear stimulation, providing hope for osteoarthritis to 654 million adults worldwide.
The pilot study involved 30 participants in kneecap osteoarthritis who received 60 minutes of treatment using percutaneous ear nerve stimulation (TVNS). The device is present in the ear, sending electrical pulses to stimulate the ear branch of the vagus nerve.
What makes this approach different from traditional knee pain treatments? Instead of focusing directly on the damaged knee joint, the researchers targeted the central pain mechanism, the way pain signals in the brain and nervous system processes.
Real-time pain relief
“As a physical therapist, I see many patients suffering from OA knee pain,” said Kosaku Aoyagi, PhD, assistant professor of physical therapy and exercise science at UTEP School of Health Sciences. “This prompted me to continue research to improve their quality of life and our results showed strong potential.”
The results are encouraging. The average knee pain was relieved immediately after treatment, with an average of 1.27 points of relief, and 1.87 points after 15 minutes decreased with a 10-minute pain scale. More importantly, 11 of the 30 participants (37% of the research team) called the “minimal clinically important improvement”, meaning that pain relief is enough to make their daily lives a real impact.
The treatment is to address imbalances in the nervous system, which researchers believe can lead to chronic pain. The vagus nerve plays a crucial role in the parasympathetic nervous system, which controls the body’s “rest and digest” function.
Beyond the Knee: How the Brain Mechanism Drives Pain
“The current evidence suggests that individuals with OA knee pain have imbalanced sympathetic and parasympathetic activity in their body, which may cause pain,” Aoyagi explained. “By stimulating the vagus, we hypothesized that our treatment may correct this imbalance.”
The study reveals fascinating insights about treatment modes. The researchers measured heart rate variability-markers of parasympathetic function and found significant improvements after treatment. The high-frequency power of heart rate variability increased by an average of 234 ms squared, indicating enhanced parasympathetic activity.
Perhaps most interestingly, the study shows that treatment improves regulatory pain regulation (CPM), a measure of the working effect of the brain’s natural pain relief system. This suggests that ear stimulation is actually changing the way participants’ nervous system processes pain signals, rather than just masking symptoms.
Safety and patient experience
Given that participants were averaging 55 years old, mainly including Hispanic participants (83%), safety was the main problem for the researchers. All 30 participants completed a full hour of treatment without major complications.
Only two participants suffered minor side effects: one felt a brief nausea and the other developed a brief dizziness immediately after treatment. Both symptoms resolve within minutes. It is worth noting that 93% of participants said they would return to additional meetings if proposed.
The FDA has approved TVN for the treatment of depression and epilepsy, but this represents the first U.S. study to evaluate its effectiveness against knee pain. Current treatments for knee osteoarthritis are usually only moderately effective and often bring about unnecessary side effects.
The science behind stimulation
The treatment targets specific areas of the ear, called Cymba Concha, which is connected only to the vagus nerve. The researchers used precise electrical parameters (25 Hz frequency, 25 Hz frequency with 250 microsecond pulses – the researchers made sure they activated the correct neural pathway.
It is particularly noteworthy that participants did not improve in certain pain sensitivity measures (such as pressure pain threshold or time summation). This suggests that treatment is primarily through the brain’s declining pain control system rather than altering local pain sensitivity, a finding that could guide future therapeutic development.
Looking to the future: From pilot to practice
“Dr. Aoyagi’s research on knee osteoarthritis is an innovative step in identifying treatments that successfully relieve knee pain,” said Dr. Stacy Wagovich, interim dean of the School of Health Sciences. “With the large-scale research in the future, the work of his team has the potential to greatly improve the treatment options for knee osteoarthritis.”
This treatment has not been provided to the public yet. The researchers acknowledged several limitations of their pilot study, including the lack of a control group and the use of only one treatment course. The next step involved conducting a larger randomized controlled trial, with participants divided into treatment and placebo groups.
For millions of people whose daily activities (from tying shoelaces to climbing stairs) are limited by knee pain, the study takes a glimpse of the future, where reliefs may not come from pills or injections, but from simple devices that fit the ear. The path from the laboratory to the clinic is still long, but early results suggest that this unconventional approach to ancient problems deserves serious concern.
If our report has been informed or inspired, please consider donating. No matter how big or small, every contribution allows us to continue to provide accurate, engaging and trustworthy scientific and medical news. Independent news takes time, energy and resources – your support ensures that we can continue to reveal the stories that matter most to you.
Join us to make knowledge accessible and impactful. Thank you for standing with us!
